Recent Finacing
Recent Raise
Funxional Therapeutics is a Cambridge clinical-stage pharmaceutical developing chemokine inhibitors; oral small molecule FX125L completed Phase I and is ready for Phase II while backups advance preclinically.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors